Miriam Schmidts
Has grant
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
Recent Grants
Grant: Close
TREATCilia
Open Date: 2017-02-01
Close Date: 2022-01-01
Grant: Close
Deciphering the molecular basis of ciliopathies resulting from cytoplasmic dynein-2 dysfunction
Open Date: 2015-01-01
Close Date:
Grant: Close
SFB-1140 (KIDGEM); subproject B06: Organspezifische Pathogenese von ziliären Signaldefekten
Open Date: 2015-01-01
Close Date:
Grant: Close
Organ-specific outcomes in ciliary signaling defects (B06)
Open Date: 2015-01-01
Close Date:
Grant: Close
Hypatia Fellowship
Open Date: 2014-11-01
Close Date:
Articles (17)
Year:
2024
Year:
2024
Year:
2024
Year:
2023
Year:
2023
Primary cilia project from the surface of most vertebrate cells and are key in sensing extracellular signals and locally transducing this information into a cellular response. Recent findings show that primary cilia are not merely static organelles with a distinct lipid and protein composition. Instead, the function of primary cilia relies on the dynamic composition of molecules within the cilium, the context‐dependent sensing and processing of extracellular stimuli, and cycles of assembly and disassembly in a cell‐ and tissue‐specific manner. Thereby, primary cilia dynamically integrate different cellular inputs and control cell fate and function during tissue development. Here, we review the recently emerging concept of primary cilia dynamics in tissue development, organization, remodeling, and function.
Year:
2023
Riboflavin transporter 1 (RFVT1) deficiency is an ultrarare metabolic disorder due to autosomal dominant pathogenic variants in SLC52A1. The RFVT1 protein is mainly expressed in the placenta and intestine. To our knowledge, only five cases of RFVT1 deficiency from three families have been reported so far. While newborns and infants with SLC52A1 variants mainly showed a multiple acyl-CoA dehydrogenase deficiency-like presentation, individuals identified in adulthood were usually clinically asymptomatic. We report two patients with novel heterozygous SLC52A1 variants. Patient 1 presented at the age of 62 with mild hyperammonemia following gastroenteritis. An acylcarnitine analysis in dried blood spots was abnormal with a multiple acyl-CoA dehydrogenase deficiency-like pattern, and genetic analysis confirmed a heterozygous SLC52A1 variant, c.68C > A, p. Ser23Tyr. Patient 2 presented with recurrent seizures and hypsarrhythmia at the age of 7 months. Metabolic investigations yielded unremarkable results. However, whole exome sequencing revealed a heterozygous start loss variant, c.3G > A, p. Met1Ile in SLC52A1. These two cases expand the clinical spectrum of riboflavin transporter 1 deficiency and demonstrate that symptomatic presentation in adulthood is possible.
Year:
2023
Year:
2023
Year:
2022
Year:
2022
Year:
2022
Year:
2021
Year:
2021
Year:
2021
Year:
2021
Year:
2021
Year:
2020
Collaborators (15)
Ute Spiekerkoetter
University Medical Center Freiburg
David U. Mick
Professor
Saarland University
Dagmar Wachten
-
Tadahiro Mitani
Jichi Medical University
Nicole van der Wel
Head Electron Microscopy/ Assistant Professor
AMC Research Institute
Dimitra Micha
principal investigator/assistant professor
Amsterdam UMC Locatie VUmc
Gregory J. Pazour
-
Sheng-Jia Lin
Assistant Professor
Utah Tech University
Michael Schrader
Professor
University of Exeter
Matthew Guille
Academic, Professor, Professor of Developmental Genetics
University of Portsmouth
Shreeram Akilesh
Associate Professor
University of Washington
Nathalie Jurisch-Yaksi
Norwegian University of Science and Technology
Anke Schumann
Clinical head of diagnostic metabolic laboratory
-
Thibaut Eguether
Assistant Professor Biochemistry
Sorbonne Université
Paolo Uva
Istituto Giannina Gaslini
Make your next move.
Prepare your application
Review drafts before you send them.